In a population-based study using the Munich Cancer Registry, Engel et al20 compared the overall mortality (OM) and relative survival of OMPC patients undergoing CRP (n = 688) and in patients who have not received local treatment (n = 250). The gene discussed is CRP; the disease is cancer.